We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$1.56B
AUM Growth
+$82.6M
Cap. Flow
+$9.05M
Cap. Flow %
0.58%
Top 10 Hldgs %
50.01%
Holding
338
New
18
Increased
55
Reduced
91
Closed
21

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
COWZ icon
Pacer US Cash Cows 100 ETF
COWZ
+$11.8M
3
JPM icon
JPMorgan Chase
JPM
+$5.37M
4
AAPL icon
Apple
AAPL
+$5.1M
5
BAC icon
Bank of America
BAC
+$3.88M

Sector Composition

Rank Sector Weight
1 Healthcare 11.26%
2 Technology 8.53%
3 Financials 8.13%
4 Communication Services 4.48%
5 Energy 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOLF icon
176
Wolfspeed
WOLF
$1.65B
$568K 0.04%
8,751
MGM icon
177
MGM Resorts International
MGM
$11.1B
$566K 0.04%
12,750
ALL icon
178
Allstate
ALL
$64.7B
$566K 0.04%
5,108
GLD icon
179
SPDR Gold Trust
GLD
$144B
$565K 0.04%
3,083
IEMG icon
180
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
$537K 0.03%
11,002
-187
-2% -$9.17K
ABT icon
181
Abbott
ABT
$192B
$535K 0.03%
5,283
-970
-16% -$102K
VZ icon
182
Verizon
VZ
$195B
$511K 0.03%
13,139
-202
-2% -$7.97K
DLB icon
183
Dolby
DLB
$5.75B
$509K 0.03%
5,953
CSX icon
184
CSX Corp
CSX
$92.8B
$507K 0.03%
16,943
SON icon
185
Sonoco
SON
$5.74B
$506K 0.03%
8,300
BCRX icon
186
BioCryst Pharmaceuticals
BCRX
$2.71B
$506K 0.03%
60,633
IBM icon
187
IBM
IBM
$222B
$505K 0.03%
3,856
+5
+0.1% +$669
VDC icon
188
Vanguard Consumer Staples ETF
VDC
$7.96B
$502K 0.03%
2,596
GPC icon
189
Genuine Parts
GPC
$18.5B
$502K 0.03%
3,000
MFIC icon
190
MidCap Financial Investment
MFIC
$795M
$499K 0.03%
43,733
ORCL icon
191
Oracle
ORCL
$442B
$496K 0.03%
5,342
-1,993
-27% -$175K
PODD icon
192
Insulet
PODD
$10.1B
$496K 0.03%
1,555
KMB icon
193
Kimberly-Clark
KMB
$36.2B
$495K 0.03%
3,688
HCA icon
194
HCA Healthcare
HCA
$89.8B
$490K 0.03%
1,860
-518
-22% -$132K
SBUX icon
195
Starbucks
SBUX
$124B
$488K 0.03%
4,684
+1
+0% +$104
JAZZ icon
196
Jazz Pharmaceuticals
JAZZ
$16.2B
$479K 0.03%
3,270
TSLX icon
197
Sixth Street Specialty
TSLX
$1.79B
$476K 0.03%
26,000
EFA icon
198
iShares MSCI EAFE ETF
EFA
$80.2B
$475K 0.03%
6,641
PMN icon
199
ProMIS Neurosciences
PMN
$130M
$473K 0.03%
4,000
AA icon
200
Alcoa
AA
$13.5B
$469K 0.03%
11,020
+6,406
+139% +$309K

Similar funds

Northeast Financial Consultants's Q1 2023 Portfolio in Review

As of Q1 2023, Northeast Financial Consultants held 338 positions worth $1.56B, up 5.6% from $1.48B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Northeast Financial Consultants's Q1 2023 filing shows 18 new, 55 increased, 91 reduced and 21 closed positions. Its largest new stake was Texas Instruments: 11,750 shares worth $2.19M. The largest sale was Vanguard S&P 500 ETF, an estimated $4.75M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

  • Northeast Financial Consultants's largest Q1 2023 buy was Texas Instruments: 11,750 shares worth $2.19M.
  • Northeast Financial Consultants added most to Pfizer in Q1 2023, an estimated $30M increase.
  • Northeast Financial Consultants's biggest Q1 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $4.75M.
  • Northeast Financial Consultants fully exited Brookfield Asset Management in Q1 2023, selling an estimated $1.35M.
  • Northeast Financial Consultants's ten largest holdings make up 50% of its $1.56B portfolio in Q1 2023.
  • Northeast Financial Consultants opened 18 new positions and closed 21 in Q1 2023.
  • Northeast Financial Consultants's portfolio value rose 5.6% quarter-over-quarter to $1.56B.

Based on Northeast Financial Consultants's 13F filing for Q1 2023, filed 15 May 2023.